You just read:

BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults

News provided by

Biondvax Pharmaceuticals Ltd

Jun 29, 2015, 03:47 ET